title: Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study.
abstract: OBJECTIVE
  To determine the prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with a history of myocardial infarction (MI) and cholesterol levels lower than 240 mg/dL.
  
  
  METHODS
  A cross-sectional analysis was conducted at baseline of 4159 participants in the Cholesterol and Recurrent Events (CARE) Study. Symptomatic diffuse atherosclerosis was defined as a history of MI plus lower extremity or cerebrovascular atherosclerosis or claudication by Rose questionnaire.
  
  
  RESULTS
  The prevalence of symptomatic diffuse atherosclerosis was 12.9%; 353 participants (8.5%) had lower extremity disease and 219 (5.3%) had cerebrovascular disease. After controlling for other variables, diffuse atherosclerosis was associated with age (Odds Ratio [OR] = 1.44 per ten-year increase), systolic blood pressure (OR = 1.13 per 10 mm Hg increase), a history of multiple myocardial infarctions (OR = 1.76), diabetes (OR = 1.76), hypertension (OR = 1.38), reduced exercise performance (OR = 1.55), current smoking status (OR = 2.87), and lower alcohol intake (OR = 0.97 per drink per week). There was no association with race, gender, or lipid levels.
  
  
  CONCLUSIONS
  The presence of clinically evident diffuse atherosclerosis is common and is associated with several modifiable risk factors. Early identification of these individuals could affect treatment and clinical outcomes.
authors.affiliation: Section of General Internal Medicine, Minneapolis VA Medical Center, MN, USA.
authors.forename: T J
authors.initials: TJ
authors.lastname: Wilt
authors.forename: B R
authors.initials: BR
authors.lastname: Davis
authors.forename: D G
authors.initials: DG
authors.lastname: Meyers
authors.forename: J L
authors.initials: JL
authors.lastname: Rouleau
authors.forename: F M
authors.initials: FM
authors.lastname: Sacks
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000453:epidemiology*; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology; D016017:Odds Ratio; D016491:Peripheral Vascular Diseases / Q000453:epidemiology*; D017035:Pravastatin / Q000627:therapeutic use; D015995:Prevalence; D012008:Recurrence; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology
chemical_list: D000924:Anticholesteremic Agents; D002784:Cholesterol; D017035:Pravastatin